EyePoint (EYPT) Short-term Investments (2011 - 2026)
EyePoint (EYPT) reported Short-term Investments of $144.8 million for Q1 2026, down 37.85% on a YoY basis from $233.0 million in Q1 2025, and down 29.1% sequentially from $204.3 million in Q4 2025.
EyePoint (EYPT) Short-term Investments (2011 - 2026) Analysis & Trends
EyePoint (EYPT) has 13 years of Short-term Investments data on file, last reported at $144.8 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments fell 37.85% year-over-year to $144.8 million; the trailing twelve-month figure through Mar 2026 stood at $144.8 million (down 37.85% YoY), and the FY2025 full-year result was $204.3 million, down 24.68% from the prior year.
- Short-term Investments eased to $144.8 million in Q1 2026, from $204.3 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $271.2 million in Q4 2024 to a low of $2.9 million in Q2 2023.
- A 5-year average of $114.2 million and a median of $89.2 million in 2022 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments plunged 96.74% in 2023 and jumped 6433.76% in 2024, its largest moves.
- Tracing EYPT's Short-term Investments over 5 years: stood at $48.9 million in 2022, then grew by 1.76% to $49.8 million in 2023, then surged by 444.74% to $271.2 million in 2024, then dropped by 24.68% to $204.3 million in 2025, then dropped by 29.1% to $144.8 million in 2026.
- Business Quant data shows EYPT's Short-term Investments at $144.8 million in Q1 2026, $204.3 million in Q4 2025, and $129.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144.83 Mn |
| Dec 31, 2025 | 204.27 Mn |
| Sep 30, 2025 | 129.45 Mn |
| Jun 30, 2025 | 184.59 Mn |
| Mar 31, 2025 | 233.04 Mn |
| Dec 31, 2024 | 271.21 Mn |
| Sep 30, 2024 | 173.96 Mn |
| Jun 30, 2024 | 189.48 Mn |
| Mar 31, 2024 | 28.34 Mn |
| Dec 31, 2023 | 49.79 Mn |
| Sep 30, 2023 | 2.98 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 16.70 Mn |
| Dec 31, 2022 | 48.93 Mn |
| Sep 30, 2022 | 81.90 Mn |
| Jun 30, 2022 | 89.03 Mn |
| Mar 31, 2022 | 89.24 Mn |
| Dec 31, 2021 | 32.97 Mn |
| Mar 31, 2017 | 2.50 Mn |
| Dec 31, 2016 | 5.85 Mn |